All Stories

  1. Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study

    Article • Mediators of Inflammation, February 2019, Hindawi Publishing Corporation

    Professor Gianni Virgili, Luca Cantarini

  2. The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet’s Disease

    Article • Ocular Immunology and Inflammation, August 2018, Taylor & Francis

    Luca Cantarini

  3. Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease

    Article • Ocular Immunology and Inflammation, October 2017, Taylor & Francis

    Luca Cantarini

  4. Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis

    Article • Medicine, July 2015, Wolters Kluwer Health

    Luca Cantarini

  5. Long-Term Efficacy of Interleukin-1 Receptor Antagonist (Anakinra) in Corticosteroid-Dependent and Colchicine-Resistant Recurrent Pericarditis

    Article • The Journal of Pediatrics, June 2014, Elsevier

    Luca Cantarini

  6. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis

    Article • Clinical Rheumatology, April 2014, Springer Science + Business Media

    Luca Cantarini

  7. Anakinra treatment in patients with gout and type 2 diabetes

    Article • Clinical Rheumatology, April 2014, Springer Science + Business Media

    Luca Cantarini

  8. Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab

    Article • Clinical Rheumatology, April 2014, Springer Science + Business Media

    Luca Cantarini

  9. Efficacy of tocilizumab in a patient with refractory psoriatic arthritis

    Article • Clinical Rheumatology, April 2014, Springer Science + Business Media

    Luca Cantarini

  10. Possible chondroprotective effect of canakinumab: An in vitro study on human osteoarthritic chondrocytes

    Article • Osteoarthritis and Cartilage, April 2014, Elsevier

    Luca Cantarini

  11. Serum amyloid-A in Behçet’s disease

    Article • Clinical Rheumatology, March 2014, Springer Science + Business Media

    Luca Cantarini

  12. Blau syndrome and latent tubercular infection: an unresolved partnership

    Article • International Journal of Rheumatic Diseases, March 2014, Wiley

    Luca Cantarini

  13. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate

    Article • Clinical Rheumatology, March 2014, Springer Science + Business Media

    Luca Cantarini

  14. The enthesopathy of celiac patients: effects of gluten-free diet

    Article • Clinical Rheumatology, February 2014, Springer Science + Business Media

    Luca Cantarini

  15. The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection

    Article • Clinical Rheumatology, February 2014, Springer Science + Business Media

    Luca Cantarini

  16. Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab

    Article • Clinical Rheumatology, February 2014, Springer Science + Business Media

    Luca Cantarini

  17. Diagnosis and classification of relapsing polychondritis

    Article • Journal of Autoimmunity, February 2014, Elsevier

    Luca Cantarini

  18. Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature

    Article • Clinical Rheumatology, January 2014, Springer Science + Business Media

    Luca Cantarini

  19. Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series

    Article • Dermatology, January 2014, Karger Publishers

    Luca Cantarini

  20. Anakinra treatment in drug-resistant Behcet’s disease: a case series

    Article • Clinical Rheumatology, December 2013, Springer Science + Business Media

    Luca Cantarini

  21. The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF‐α

    Article • European Journal of Immunology, October 2013, Wiley

    Luca Cantarini, MD Pietro Enea Lazzerini

  22. Working the endless puzzle of hereditary autoinflammatory disorders

    Article • Modern Rheumatology, October 2013, Oxford University Press (OUP)

    Luca Cantarini

  23. Correction: First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)

    Article • PLoS ONE, October 2013, PLOS

    Luca Cantarini

  24. First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)

    Article • PLoS ONE, September 2013, PLOS

    Luca Cantarini, Professor Michael McDermott

  25. The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome

    Article • International Journal of Rheumatic Diseases, July 2013, Wiley

    Luca Cantarini

  26. Glucocorticoids in the Management of Systemic Juvenile Idiopathic Arthritis

    Article • Pediatric Drugs, June 2013, Springer Science + Business Media

    Luca Cantarini

  27. Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis

    Article • Internal Medicine Journal, June 2013, Wiley

    Luca Cantarini

  28. Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined

    Article • Reumatismo, May 2013, PAGEPress Publications

    Luca Cantarini

  29. Improved Efficacy of Intramuscular Weekly Administration of Clodronate 200 mg (100 mg Twice Weekly) Compared with 100 mg (Once Weekly) for Increasing Bone Mineral Density in Postmenopausal Osteoporosis

    Article • Clinical Drug Investigation, March 2013, Springer Science + Business Media

    Luca Cantarini

  30. Antiangiogenic VEGF Isoform in Inflammatory Myopathies

    Article • Mediators of Inflammation, January 2013, Hindawi Publishing Corporation

    Luca Cantarini

  31. From the Mediterranean to the Sea of Japan: The Transcontinental Odyssey of Autoinflammatory Diseases

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Luca Cantarini

  32. Caution Should be Used in the Recognition of Adult-Onset Autoinflammatory Disorders: Facts or Fiction?

    Article • Frontiers in Immunology, January 2013, Frontiers

    Luca Cantarini

  33. Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders

    Article • Mediators of Inflammation, January 2013, Hindawi Publishing Corporation

    Luca Cantarini

  34. Weekly oral alendronate in mevalonate kinase deficiency

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Luca Cantarini

  35. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives

    Article • Autoimmunity Reviews, November 2012, Elsevier

    Luca Cantarini

  36. The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature

    Article • Autoimmunity Reviews, November 2012, Elsevier

    Luca Cantarini

  37. Recurrent pericarditis: Autoimmune or autoinflammatory?

    Article • Autoimmunity Reviews, November 2012, Elsevier

    Luca Cantarini

  38. Acute idiopathic pericarditis: current immunological theories

    Article • Research Reports in Clinical Cardiology, September 2012, Taylor & Francis

    Luca Cantarini, Massimo Imazio

  39. Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab

    Article • Annals of Internal Medicine, June 2012, American College of Physicians

    Luca Cantarini

  40. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome

    Article • Annals of the Rheumatic Diseases, June 2012, BMJ

    Luca Cantarini, Professor Michael McDermott

  41. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study

    Article • Clinical Research in Cardiology, February 2012, Springer Science + Business Media

    Luca Cantarini

  42. What Do Cytokine Profiles Tell Us About Subsets of Juvenile Idiopathic Arthritis?

    Article • Current Rheumatology Reports, January 2012, Springer Science + Business Media

    Luca Cantarini

  43. Serum Amyloid A Circulating Levels and Disease Activity in Patients with Juvenile Idiopathic Arthritis

    Article • Yonsei Medical Journal, January 2012, Yonsei University College of Medicine (KAMJE)

    Luca Cantarini

  44. Treatment strategies for childhood noninfectious chronic uveitis: an update

    Article • Expert Opinion on Investigational Drugs, November 2011, Informa Healthcare

    Luca Cantarini

  45. Erratum to “Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis” [J. Autoimmun. Rev. 9(6) (2010) 436–440]

    Article • Autoimmunity Reviews, November 2011, Elsevier

    Luca Cantarini

  46. Clinical and biochemical landmarks in systemic autoinflammatory diseases

    Article • Annals of Medicine, October 2011, Taylor & Francis

    Luca Cantarini

  47. The laboratory approach in the diagnosis of systemic autoinflammatory diseases

    Article • Reumatismo, September 2011, PAGEPress Publications

    Luca Cantarini

  48. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease

    Article • Rheumatology International, March 2011, Springer Science + Business Media

    Luca Cantarini

  49. Monogenic autoinflammatory syndromes at a dermatological level

    Article • Archives of Dermatological Research, February 2011, Springer Science + Business Media

    Luca Cantarini

  50. Autoinflammatory diseases and cardiovascular manifestations

    Article • Annals of Medicine, February 2011, Taylor & Francis

    Luca Cantarini

  51. Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations

    Article • JIMD Reports, January 2011, Springer Science + Business Media

    Luca Cantarini

  52. Role of Autoimmunity and Autoinflammation in the Pathogenesis of Idiopathic Recurrent Pericarditis

    Article • Clinical Reviews in Allergy & Immunology, December 2010, Springer Science + Business Media

    Luca Cantarini

  53. Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there?

    Article • Rheumatology International, December 2010, Springer Science + Business Media

    Luca Cantarini

  54. Kawasaki syndrome and concurrent Coxsackie virus B3 infection

    Article • Rheumatology International, October 2010, Springer Science + Business Media

    Luca Cantarini

  55. Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet's disease: an international cohort study of 110 patients. One-year follow-up data

    Article • Rheumatology, October 2010, Oxford University Press (OUP)

    Luca Cantarini

  56. Current therapeutic approaches to autoimmune chronic uveitis in children

    Article • Autoimmunity Reviews, August 2010, Elsevier

    Luca Cantarini

  57. Colchicine Myopathy and Neuromyopathy

    Article • JCR Journal of Clinical Rheumatology, August 2010, Wolters Kluwer Health

    Luca Cantarini

  58. Autoinflammatory disorders and patients with isolated serosal involvement

    Article • Rheumatology International, May 2010, Springer Science + Business Media

    Luca Cantarini

  59. Typical and severe tumor necrosis factor receptor–associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series

    Article • Rheumatology International, May 2010, Springer Science + Business Media

    Luca Cantarini

  60. Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis

    Article • Autoimmunity Reviews, April 2010, Elsevier

    Luca Cantarini

  61. Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis

    Article • Rheumatology International, March 2010, Springer Science + Business Media

    Luca Cantarini

  62. Short- and Long-Term Effects of Spa Therapy in Knee Osteoarthritis

    Article • American Journal of Physical Medicine & Rehabilitation, February 2010, Wolters Kluwer Health

    Luca Cantarini

  63. Serosal Involvement in Adult-Onset Autoinflammatory Disorders

    Article • Respiration, January 2010, Karger Publishers

    Luca Cantarini

  64. Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene

    Article • Rheumatology International, January 2010, Springer Science + Business Media

    Luca Cantarini

  65. Possible Implication of Local Immune Response in Darier's Disease: An Immunohistochemical Characterization of Lesional Inflammatory Infiltrate

    Article • Mediators of Inflammation, January 2010, Hindawi Publishing Corporation

    Luca Cantarini

  66. Th17 Transcription Factor RORC2 Is Inversely Correlated with FOXP3 Expression in the Joints of Children with Juvenile Idiopathic Arthritis

    Article • The Journal of Rheumatology, July 2009, The Journal of Rheumatology

    Luca Cantarini

  67. Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis

    Article • Rheumatology International, June 2009, Springer Science + Business Media

    Luca Cantarini

  68. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms

    Article • Journal of Clinical Pathology, January 2009, BMJ

    Luca Cantarini

  69. Atypical Juvenile Polymyositis

    Article • JCR Journal of Clinical Rheumatology, October 2008, Wolters Kluwer Health

    Luca Cantarini

  70. Efficacy of Alendronate in the Treatment of the SAPHO Syndrome

    Article • JCR Journal of Clinical Rheumatology, June 2008, Wolters Kluwer Health

    Luca Cantarini

  71. Sulfasalazine-induced immune thrombocytopenia

    Article • Postgraduate Medical Journal, June 2007, Oxford University Press (OUP)

    Luca Cantarini

  72. Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial

    Article • Rheumatology International, November 2006, Springer Science + Business Media

    Luca Cantarini

  73. Effect of hyaluronic acid (MW 500–730kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure

    Article • Osteoarthritis and Cartilage, August 2005, Elsevier

    Luca Cantarini

  74. Methods Used to Assess Clinical Outcome and Quality of Life in Osteoarthritis

    Article • Seminars in Arthritis and Rheumatism, October 2004, Elsevier

    Luca Cantarini